Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| United Therapeutics Corporation(UTHR) | 100,332 | 92,057 | -8,275 | $36.0K | $32.5K | 19.22% | -$3.5K |
| Exelixis, Inc.(EXEL) | 1,281,612 | 965,866 | -315,746 | $33.3K | $32.2K | 19.03% | -$1.1K |
| Cardinal Health, Inc.(CAH) | 210,263 | 208,845 | -1,418 | $23.2K | $24.7K | 14.61% | +$1.5K |
| Biogen Inc.(BIIB) | 113,502 | 108,923 | -4,579 | $22.0K | $16.7K | 9.85% | -$5.3K |
| Jazz Pharmaceuticals plc(JAZZ) | 110,257 | 105,803 | -4,454 | $12.3K | $13.0K | 7.71% | +$746 |
| Enanta Pharmaceuticals, Inc.(ENTA) | 1,498,074 | 2,117,390 | +619,316 | $15.5K | $12.2K | 7.20% | -$3.3K |
| Indivior Plc | 701,873 | 935,680 | +233,807 | $6.8K | $11.6K | 6.88% | +$4.8K |
| BioNTech SE(BNTX) | 93,583 | 88,663 | -4,920 | $11.1K | $10.1K | 5.98% | -$1.0K |
| Sanofi(SNY) | 150,205 | 149,196 | -1,009 | $8.7K | $7.2K | 4.26% | -$1.5K |
| Alkermes plc(ALKS) | 251,495 | 238,136 | -13,359 | $7.0K | $6.8K | 4.05% | -$190 |
| Vanda Pharmaceuticals Inc.(VNDA) | 414,684 | 378,762 | -35,922 | $1.9K | $1.8K | 1.07% | -$131 |
| Mural Oncology Plc | 75,868 | 70,163 | -5,705 | $237 | $226 | 0.13% | -$11 |
| Regeneron Pharmaceuticals, Inc.(REGN) | 353 | 0 | -353 | $371 | $0 | — | -$371 |